2019, Feb. 26-27: Animal Health Investment Europe 2019
26 January 2019 Come and see us at the conference Animal Health Investment Europe 2019, London.
2018, Oct. 29-31: VEROVACCiNES GmbH to present at the 18th Annual World Vaccine Congress, Lisbon, Portugal.
29 September 2018 The current status of VEROVACCiNES multivalent subunit marker vaccine development will be presented by CEO Dr. Hanjo Hennemann at the 18th Annual World Vaccine Congress, Lisbon Portugal from 29-31 October 2018.The World Veterinary Vaccine Congress brings animal health industry experts from the whole value chain under one roof to discuss scientific, regulatory […]
2017, June 12-14: VEROVACCiNES presents as selected emerging company at VETHEALTH GLOBAL 2017
12 March 2017 The selection committee of the VETHEALTH GLOBAL 2017 conference (Charlottetown, Prince Edward Island, Canada) selected VEROVACCiNES as emerging company to present at the Innovation Spotlight Series. The biennial conference, hosted by the PEI BioAlliance, is a gathering place for international industry leaders to discuss emerging market trends, global regulatory issues, and innovative developments […]
2017, Feb. 22-23: VEROVACCiNES selected as Emerging Company at ANIMAL HEALTH INVESTMENT Europe, London UK conference 2017.
22 January 2017 The selection committee of the conference ANIMAL HEALTH INVESTMENT Europe, London UK, selected the startup project VEROVACCiNES as one of 12 presenting emerging companies. VEROVACCiNES is the only “yet to be founded” participant.This conference is dedicated to showcasing to investors the most innovative emerging animal health companies covering the companion, aquaculture and […]